SITC Archive Library

2020-2021 Advances in Cancer Immunotherapy™ Webinar Series - Clinical Updates from ESMO Immuno-Oncology Congress 2020 - Recorded Webinar and Presentation Slides 

07-08-2021 12:16

On July 16, 2021, leading experts in cancer immunotherapy discussed the latest advances in cancer immunotherapy emerging from ESMO Immuno-Oncology Virtual Congress 2020. The recorded webinar and presentation slides are available below.

Indicates this content is not available on-demand. 

Webinar Faculty:

  • Moderator: Paolo A. Ascierto, MD – Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale'
  • Presenters:
    • Sunandana Chandra, MD, MS – Northwestern University
    • Julia Katharina Schwarze, MD, MSc – University Hospital Brussels

Joseph Sacco, MBChB, MSc, MRCP, PhD – The Clatterbridge Cancer Centre

Featured Presentations:

  • A Phase (ph) 2, Multi-Center Study of the Safety and Efficacy of tebentafusp (tebe) (IMCgp100) in Patients (pts) with Metastatic Uveal Melanoma (mUM) - Presenter: Joseph Sacco, MBChB, MSc, MRCP, PhD
  • A phase I clinical trial on intratumoral (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma - Julia Katharina Schwarze, MD, MSc
  • Additional clinical abstracts of interest from ESMO Immuno-Oncology Congress 2020 will be presented by Sunandana Chandra, MD, MS


Please note that the on-demand webinar is not available for continuing education credits.

Statistics
0 Favorited
143 Views
3 Files
0 Shares
30 Downloads

You Must Be Logged In To Access This Resource

This library resource entry requires a SITC CONNECT account. Click the Sign In button at the top of this page, otherwise click here to create a FREE SITC CONNECT.

With a free SITC CONNET account, you can begin accessing hundreds of cancer immunotherapy resources in the SITC CONNECT Archive and Resource Libraries. Once your account is created, return to this page, refresh, and a download link should appear.

Tags and Keywords

Related Entries and Links

No Related Resource entered.